Patients with rare diseases in India, like Saifullah Khalidi with spinal muscular atrophy (SMA), struggle to afford ...

Roche's bid to block a generic SMA drug risks public health by limiting affordable access, say patient groups, highlighting high costs and patent issues.

Several public health groups are opposing Roche seeking a permanent injunction against Natco Pharma to prevent the ...

The votes are in and the counting will provide us with a growing picture of who the next US President will be.

Known for his energetic analysis and “Kornacki Khakis,” he’s become a fan favourite on Election Day, breaking down complex ...

The former loose forward believes the Boks and Scotland will both be playing different game plans than previously seen during their match on Sunday.

The US FDA has approved Vyloy in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of advanced gastric or gastroesophageal junction cancer.

Roche’s first hot ‘kūmara’Brian Roche begins his job as public service commissioner this week, and the appointment of an ...

Mark Laroche, president and CEO of the YOW Authority, has been named Newsmaker of the Year for 2024 by the Ottawa Business ...

Ten agonising days after he was last seen alive, the family of missing Wexford man Brandon Roche were granted some small ...

Patient advocates push for generic drug production to treat rare diseases, facing patent barriers and high costs.

Placing the concept of income tax cuts aside, arguably the most popular aspect of Gov. Jeff Landry’s wide-ranging special ...